Please assess the completion status of the following clinical trial:

Trial Title: Nutritional Support for Lactating Women and Azithromycin to Infants - Mumta Lactating Women Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Mid-upper-arm-circumference of lactating women less than 23.0 cm, whose birth outcome should be captured within 168 hours~* Singleton alive baby~* Intention to stay in the catchment area for the entire duration of the trial after enrolment~* Intention to breastfeed the child for at least 6 months~* Voluntary written consent~Exclusion Criteria:~* Weight of newborn at first assessment, within 168 hours of birth is less than 1500 gm~* Newborn with known congenital anomaly or sign of serious illness based of study physician's assessment before enrollment.~* Lactating women has known allergies to peanut, lentils, chickpea or dairy products.~* Lactating woman who have some serious medical illness/condition due to which she is not able to or not willing to breastfeed the child, like breast cancer, inverted nipples.~* Previous enrolment in the same trial.

- Gender: FEMALE
- Minimum Age: 13 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Arm A (Type: NO_INTERVENTION): Control arm: Lactating women (LW) randomized in this arm will only receive standard of care which comprises of standard nutritional counseling, key messages of exclusive breastfeeding, essential newborn and infant care and immunization.
- Arm B (Type: EXPERIMENTAL): Intervention arm B: Lactating women (LW) randomized in this arm will receive ready-to-use nutritional supplement, 'Balanced energy-protein (BEP)' for next 6 months to be consumed in a dose of 2 sachets of 75 grams per day. Further, LW will also receive standard of care which comprises of standard nutritional counseling, key messages of exclusive breastfeeding, essential newborn and infant care and immunization.
- Arm C (Type: EXPERIMENTAL): Intervention arm B: Lactating women (LW) randomized in this arm will receive ready-to-use nutritional supplement, 'Balanced energy-protein (BEP)' for next 6 months to be consumed in a dose of 2 sachets of 75 grams per day. Further, the same infant of LW will receive a single dose of Azithromycin (20mg/kilogram) at day 42 of age. Further, LW will also receive standard of care which comprises of standard nutritional counseling, key messages of exclusive breastfeeding, essential newborn and infant care and immunization.

Based on this trial design, predict the completion outcome and termination type (if applicable).